Global Intravenous
Solution Market, By Solution (Saline (Normal Saline (0.9% NaCl) and
Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins &
Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large
Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By
Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution,
Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics,
Ambulatory Surgery Centers, and Home Care Settings), and By Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was
valued at US$ 8,372.0 million in 2019,
and is expected to exhibit a CAGR of 6.1% over the forecast period (2019 -
2027), as highlighted in a new report published by.
Increasing cases of kidney
failures are expected to lead to high adoption of dialysis procedures, which is
expected to drive the market growth over the forecast period. Kidney failure is
a condition in which the kidney loses its functioning ability of removing waste
and extra fluids from the body. Dialysis procedure is recommended for such
conditions. For instance, according to the National Kidney Foundation
Factsheet, in March 2015, an estimated 10% of the global population was
affected by chronic kidney disease (CKD), and around 2 million people received
treatment for kidney failure. Moreover, according to the National Institute of
Health (NIH), in December 2016, an estimated 661,000 people in the U.S.
suffered from kidney failure. Among these, around 468,000 patients were on
dialysis, and around 193,000 underwent kidney transplant procedures. According
to the same source, around 88.2% of end-stage renal disease (ESRD) patients in
the U.S. underwent renal replacement therapy with hemodialysis. 9.0% of these
patients received peritoneal dialysis, and 2.6% had received kidney transplant
in 2013.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1134
Browse 34 Market Data Tables and
35 Figures spread through 215 Pages and in-depth TOC on "Intravenous
Solution Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic
Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals,
Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume
Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By
Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution,
Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics,
Ambulatory Surgery Centers and, Home Care Settings), and By Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global
Forecast to 2027"
Major market players are focused
on development of products, which enhances patient safety and prevents IV
medication administration errors in order to avoid patient injury and lowering
pain. For instance, in March 2017, Becton, Dickinson and Company launched an IV
Medication Safety Solution, at the European Association of Hospital Pharmacists
(EAHP) congress, in France. This product was developed for prevention of IV
medication administration errors.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/intravenous-solutions-market-1134
Key Takeaways of the Intravenous
Solution Market:
The global intravenous solution
market is expected to expand at a CAGR of 6.1% over the forecast period
(2019–2027), owing to increasing cases of kidney failure and dialysis
Among solution type, the saline
solution segment is expected to account for major revenue share in 2027, owing
to increasing incidence of gastroenteritis globally. For instance, according to
the Global Burden of Disease Study, in 2015, there were two billion cases of
gastroenteritis, resulting in 1.3 million deaths globally.
Major players operating in the
global intravenous solution market include Baxter International Inc, ICU
Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC,
Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa
Parenterals Ltd, and Salius Pharma Private Limited
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1134
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment